Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I. |
| Country | Czech Republic |
| Start Date | Jan 01, 2021 |
| End Date | Dec 30, 2024 |
| Duration | 1,459 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 891397 |
Plant natural products have traditionally provided a great source of chemical scaffolds for the development of new medicines.
Following a downturn in the late 20th century, natural product research is now experiencing a renaissance owing to rapid developments in genomics and metabolomics technologies.
However, the identification of protein targets of newly discovered bioactive natural products remains very low-throughput.
Under this proposal, I will carry out research to develop a new methodology for the elucidation of molecular targets of small bioactive molecules that bind to human proteins such as membrane receptors, using stochastically-generated polymeric probes called iBodies combined with horseradish peroxidase-mediated biotin labeling.
In particular, I will focus on psychoactive metabolites from kava (Piper methysticum) called kavalactones, which have well-documented anti-anxiety properties, but their mechanism of action is unclear.
In the first stage, I will develop the molecular target identification workflow using a previously characterized ligand, resiniferatoxin, which binds with high affinity to the human pain receptor TRPV1.
Once the workflow is developed, I will proceed to identify the brain receptors that are the primary targets of natural kavalactones, as well as non-natural kavalactone derivatives that I recently developed.
In addition, I propose that a similar approach can be applied to identify liver cytochrome P450 enzymes that are inhibited by natural products such as kavalactones.
In the last stage of the project, I will develop a protocol for the extraction of liver proteins and identification of liver enzymes that interact with kavalactones. This research will deliver a new biochemical method for molecular target identification in the short term.
In the long term, it will contribute to the development of novel non-opioid psychiatric therapeutics based on the kavalactone scaffold, thus addressing an urgent need in todays European society.
Ustav Organicke Chemie A Biochemie, Av Cr, V.V.I.
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant